M61.23 Category · further specificity required Paralytic calcification and ossification of muscle, forearm
ICD-10-CM M61.23 identifies “Paralytic calcification and ossification of muscle, forearm” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 13: Diseases of the musculoskeletal system and connective tissue
Code-level instructions
No additional notes.
Inherited instructions
Chapters 13 · Diseases of the musculoskeletal system and connective tissue (M00-M99)
Excludes 210
- arthropathic psoriasis (L40.5-)
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- compartment syndrome (traumatic) (T79.A-)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Note1
Use an external cause code following the code for the musculoskeletal condition, if applicable, to identify the cause of the musculoskeletal condition
M60-M63 · Disorders of muscles (M60-M63)
Excludes 17
Excludes 21
muscular dystrophies and myopathies (G71-G72)
M61.2 · Paralytic calcification and ossification of muscle
Inclusion terms1
Myositis ossificans associated with quadriplegia or paraplegia
More specific codes
Official index references
Official index references (1)
History
Code history
Latest recorded change · FY2022 · 04-01
Effective from
- Inherited rules changed
Paralytic calcification and ossification of muscle, forearm
Category — select a more specific code
CDC/NCHS · FY2022 · 04-01All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | Inherited rules changed |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.